Quality of 2-DEOXY-2(.sup.18./sup.F)fluoro-D-glucose injection prepared by isotopic exchange of fluorine using anion exchange or liquid phase exchange catalysed with aminopolyether

0185699 - UJF-V 20027193 DE eng A - Abstract
Melichar, František - Procházka, Libor - Kropáček, Martin - Beran, Miloš
Quality of 2-DEOXY-2(¹⁸F)fluoro-D-glucose injection prepared by isotopic exchange of fluorine using anion exchange or liquid phase exchange catalysed with aminopolyether.
World Journal of Nuclear Medicine. Roč. 1, č. 2 (2002), s. 314. ISSN 1450-1147.
[Abstracts of the Congress of the World Federation of Nuclear Mecicine and Biology /8./. 29.09.2002-02.10.2002, Santiago]
R&D Projects: GA MZd NM6828; GA AV ČR KSK4055109
Keywords : 2-deoxy-2(¹⁸F) fluoro-D-glucose * injection prepared
Subject RIV: BG - Nuclear, Atomic and Molecular Physics, Colliders

Regular production of 2-deoxy-2-(¹⁸F)fluoro-D-glucose ((¹⁸F)FDG)) for Czech and Slovak PET Centers started at our upgraded U-120 cyclotrone and radiopharmaceutical laboratory. The older automatic equipment (MicroLab I) of General Electric Medical Systems (GEMS) used technology with nucleophilic substitution. Older technology was substituted with more advanced technology, MicroLab II. Nucleophilic substituon in the new technology is catalysed with aminipolyether (Kryptofix) in a luquid phase.
Permanent Link: http://hdl.handle.net/11104/0082082